26269332|t|The Human Tau Interactome: Binding to the Ribonucleoproteome, and Impaired Binding of the Proline-to-Leucine Mutant at Position 301 (P301L) to Chaperones and the Proteasome.
26269332|a|The tau protein is central to the etiology of several neurodegenerative diseases, including Alzheimer's disease, a subset of frontotemporal dementias, progressive supranuclear palsy and dementia following traumatic brain injury, yet the proteins it interacts with have not been studied using a systematic discovery approach. Here we employed mild in vivo crosslinking, isobaric labeling, and tandem mass spectrometry to characterize molecular interactions of human tau in a neuroblastoma cell model. The study revealed a robust association of tau with the ribonucleoproteome, including major protein complexes involved in RNA processing and translation, and documented binding of tau to several heat shock proteins, the proteasome and microtubule-associated proteins. Follow-up experiments determined the relative contribution of cellular RNA to the tau interactome and mapped interactions to N- or C-terminal tau domains. We further document that expression of P301L mutant tau disrupts interactions of the C-terminal half of tau with heat shock proteins and the proteasome. The data are consistent with a model whereby a higher propensity of P301L mutant tau to aggregate may reflect a perturbation of its chaperone-assisted stabilization and proteasome-dependent degradation. Finally, using a global proteomics approach, we show that heterologous expression of a tau construct that lacks the C-terminal domain, including the microtubule binding domain, does not cause a discernible shift of the proteome except for a significant direct correlation of steady-state levels of tau and cystatin B. 
26269332	4	9	Human	Species	9606
26269332	10	13	Tau	Gene	4137
26269332	90	108	Proline-to-Leucine	ProteinMutation	tmVar:p|SUB|P||L;VariantGroup:1;CorrespondingGene:4137;CorrespondingSpecies:9606
26269332	133	138	P301L	ProteinMutation	tmVar:p|SUB|P|301|L;HGVS:p.P301L;VariantGroup:0;CorrespondingGene:4137;RS#:63751273;CorrespondingSpecies:9606;CA#:225444
26269332	178	181	tau	Gene	4137
26269332	228	254	neurodegenerative diseases	Disease	MESH:D019636
26269332	266	285	Alzheimer's disease	Disease	MESH:D000544
26269332	299	323	frontotemporal dementias	Disease	MESH:D057180
26269332	325	355	progressive supranuclear palsy	Disease	MESH:D013494
26269332	360	368	dementia	Disease	MESH:D003704
26269332	379	401	traumatic brain injury	Disease	MESH:D000070642
26269332	633	638	human	Species	9606
26269332	639	642	tau	Gene	4137
26269332	648	661	neuroblastoma	Disease	MESH:D009447
26269332	717	720	tau	Gene	4137
26269332	854	857	tau	Gene	4137
26269332	1024	1027	tau	Gene	4137
26269332	1084	1087	tau	Gene	4137
26269332	1136	1141	P301L	ProteinMutation	tmVar:p|SUB|P|301|L;HGVS:p.P301L;VariantGroup:0;CorrespondingGene:4137;RS#:63751273;CorrespondingSpecies:9606;CA#:225444
26269332	1149	1152	tau	Gene	4137
26269332	1201	1204	tau	Gene	4137
26269332	1318	1323	P301L	ProteinMutation	tmVar:p|SUB|P|301|L;HGVS:p.P301L;VariantGroup:0;CorrespondingGene:4137;RS#:63751273;CorrespondingSpecies:9606;CA#:225444
26269332	1331	1334	tau	Gene	4137
26269332	1540	1543	tau	Gene	4137
26269332	1751	1754	tau	Gene	4137
26269332	1759	1770	cystatin B.	Gene	1476
26269332	Association	1476	4137
26269332	Association	MESH:D019636	4137
26269332	Association	MESH:D000070642	4137
26269332	Association	MESH:D000544	4137
26269332	Association	MESH:D013494	4137
26269332	Association	MESH:D003704	4137
26269332	Association	MESH:D057180	4137

